An Exploratory Study Evaluating the Clinical Significance of a Novel ALDH1 Activity-Detecting Probe Using Specimens from Patients with Pancreatic Cancer

An Exploratory Study Evaluating the Clinical Significance of a Novel ALDH1 Activity-Detecting Probe Using Specimens from Patients with Pancreatic Cancer - ALDH1 Probe Study for Pancreatic Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061878

Enrollment

Registered

2026-06-11

Start date

2026-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with suspected pancreatic cancer based on imaging examinations and undergoing EUS-FNA. 2. Patients who provide written informed consent for participation in this study. 3. Patients aged 20 years or older at the time of informed consent.

Exclusion criteria

Exclusion criteria: atients who are deemed unsuitable for participation in this study at the discretion of the investigator.

Design outcomes

Primary

Measure	Time frame
the proportion of probe-positive cells	—

Secondary

Measure	Time frame
1. Assessment of the correlation between the proportion of probe-positive cells and clinical and pathological characteristics 2. Assessment of the association between the proportion of probe-positive cells and patient prognosis 3. Molecular characterization of probe-positive cells	—

Countries

Japan

Contacts

Public ContactKouki Nio

Kanazawa University Department of Gastroenterology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health

nio@m-kanazawa.jp0762652235

Outcome results